Research Repository

Despite Steep Costs, Payments for New Cancer Drugs Make Economic Sense

Lichtenberg, Frank R (2011) Despite Steep Costs, Payments for New Cancer Drugs Make Economic Sense. Nature Medicine, 17 (3). p. 244. ISSN 1078-8956

Full text for this resource is not available from the Research Repository.

Abstract

Cancer drugs have become more expensive over the past few years, leading many people to question whether the treatments are really worth their high costs. But despite the sticker shock, cancer medicines have provided good value for money.

Item Type: Article
Uncontrolled Keywords: ResPubID24425, Avastin, Rituxan, Gleevec, Herceptin, cancer therapy, survival rate
Subjects: FOR Classification > 1112 Oncology and Carcinogenesis
FOR Classification > 1402 Applied Economics
SEO Classification > 970114 Expanding Knowledge in Economics
Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
Related URLs:
Depositing User: VUIR
Date Deposited: 26 Sep 2012 23:53
Last Modified: 26 Sep 2012 23:53
URI: http://vuir.vu.edu.au/id/eprint/9443
ePrint Statistics: View download statistics for this item
Citations in Scopus: 8 - View on Scopus

Repository staff only

View Item View Item

Search Google Scholar